<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0873-2159</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Pneumologia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Pneumol]]></abbrev-journal-title>
<issn>0873-2159</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Pneumologia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0873-21592008000400006</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Sarcoma pleomórfico primário do pulmão]]></article-title>
<article-title xml:lang="en"><![CDATA[Primary pleomorphic sarcoma of the lung]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Abreu]]></surname>
<given-names><![CDATA[Marcus da Matta]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Kozlowski]]></surname>
<given-names><![CDATA[Bruno Marcondes]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cordeiro]]></surname>
<given-names><![CDATA[Paulo de Biasi]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[Aureliano de]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[Marilene F]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zamboni]]></surname>
<given-names><![CDATA[Mauro]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Ministério da Saúde - MS Instituto Nacional do Câncer - INCA Hospital do Câncer - HC I]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Hospital do Câncer - HC I S. Cirurgia Torácica Oncológica ]]></institution>
<addr-line><![CDATA[Rio de Janeiro RJ]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Ministério da Saúde - MS Instituto Nacional do Câncer - INCA S. de Anatomia Patológica]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="A04">
<institution><![CDATA[,Ministério da Saúde - MS Instituto Nacional do Câncer - INCA Hospital do Câncer I]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>07</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>07</month>
<year>2008</year>
</pub-date>
<volume>14</volume>
<numero>4</numero>
<fpage>535</fpage>
<lpage>539</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S0873-21592008000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S0873-21592008000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S0873-21592008000400006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[A classificação recente da Organização Mundial da Saúde (OMS) para os tumores pulmonares unificou o heterogéneo grupo do carcinoma de não pequenas células (CPNPC), que engloba os sarcomas e os tumores com componentes sarcomatosos, sob a denominação “carcinoma com elementos pleomórficos, sarcomatóides ou sarcomatosos”. Este grupo inclui diferentes entidades, como o carcinoma pleomórfico (CP), o carcinoma de células fusiformes (CCF), carcinoma de células gigantes (CCG), os carcinossarcomas (CS) e o blastoma pulmonar (BP). De uma forma geral, estes tumores são raros e representam 0,1% a 0,4% de todas as neoplasias pulmonares. Ocorrem mais comummente em homens fumadores, com alta carga tabágica, e acomete-os em torno dos 60 anos e comummente tem evolução clínica muito agressiva. Os autores relatam o caso de um doente portador de sarcoma pleomórfico primário pulmonar e revêem a literatura sobre o assunto.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[The World Health Organization (WHO) classification of lung cancers ranks the heterogeneous nonsmall cell lung cancer (N-SCLC) group, encompassing sarcoma or sarcoma-containing tumours under one heading: “carcinomas with pleomorphic, sarcomatoid or sarcomatous elements”. This group contains entities such as pleomorphic carcinoma (PC), spindle cell carcinoma (SCC), giant cell carcinoma (GCC), carcinosarcoma (CS) and pulmonary blastoma (PB). These tumors are rare overall, making up approx. 0.1-0.4% of all lung malignancies. They are more commonly found in males who are heavy smokers, diagnosed at the age of 60 on average and follow an aggressive clinical course. The authors describe the case of a male patient with primary pleomorphic lung sarcoma and also include a review of the literature.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Neoplasias pulmonares]]></kwd>
<kwd lng="pt"><![CDATA[sarcoma pleomórfico]]></kwd>
<kwd lng="pt"><![CDATA[imunoistoquímica]]></kwd>
<kwd lng="pt"><![CDATA[neoplasia de tecidos conjuntivos e de tecidos moles]]></kwd>
<kwd lng="en"><![CDATA[Lung neoplasms]]></kwd>
<kwd lng="en"><![CDATA[pleomorphic sarcoma]]></kwd>
<kwd lng="en"><![CDATA[conective and soft tissue neoplasms]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p><b>Sarcoma pleomórfico primário do pulmão</b></p>      <p>&nbsp;</p>      <p><b>Primary pleomorphic sarcoma of the lung</b></p>      <p>&nbsp;</p>      <p><b>Marcus da Matta Abreu</b> <sup><b><a href="#1">1</a><a name="top1"></a></b></sup></p>      <p><b>Bruno Marcondes Kozlowski</b> <sup><b><a href="#2">2</a><a name="top2"></a></b></sup></p>      <p><b>Paulo de Biasi Cordeiro</b> <sup><b><a href="#3">3</a><a name="top3"></a></b></sup></p>      <p><b>Aureliano de Sousa</b> <sup><b><a href="#4">4</a><a name="top4"></a></b></sup></p>      <p><b>Marilene F Nascimento</b> <sup><b><a href="#5">5</a><a name="top5"></a></b></sup></p>      <p><b>Mauro Zamboni</b> <sup><b><a href="#6">6</a><a name="top6"></a></b></sup></p>      ]]></body>
<body><![CDATA[<p>&nbsp;</p>      <p><b>Resumo</b></p>      <p>A classificação recente da Organização Mundial da Saúde (OMS) para os tumores pulmonares unificou o heterogéneo grupo do carcinoma de não pequenas células (CPNPC), que engloba os sarcomas e os tumores com componentes sarcomatosos, sob a denominação “carcinoma com elementos pleomórficos, sarcomatóides ou sarcomatosos”.</p>      <p>Este grupo inclui diferentes entidades, como o carcinoma pleomórfico (CP), o carcinoma de células fusiformes (CCF), carcinoma de células gigantes (CCG), os carcinossarcomas (CS) e o blastoma pulmonar (BP). De uma forma geral, estes tumores são raros e representam 0,1% a 0,4% de todas as neoplasias pulmonares. Ocorrem mais comummente em homens fumadores, com alta carga tabágica, e acomete-os em torno dos 60 anos e comummente tem evolução clínica muito agressiva. Os autores relatam o caso de um doente portador de sarcoma pleomórfico primário pulmonar e revêem a literatura sobre o assunto.</p>      <p><b>Palavras-chave</b>: Neoplasias pulmonares, sarcoma pleomórfico, imunoistoquímica, neoplasia de tecidos conjuntivos e de tecidos moles.</p>      <p>&nbsp;</p>      <p><b>Abstract</b></p>      <p>The World Health Organization (WHO) classification of lung cancers ranks the heterogeneous nonsmall cell lung cancer (N-SCLC) group, encompassing sarcoma or sarcoma-containing tumours under one heading: “carcinomas with pleomorphic, sarcomatoid or sarcomatous elements”.</p>      <p>This group contains entities such as pleomorphic carcinoma (PC), spindle cell carcinoma (SCC), giant cell carcinoma (GCC), carcinosarcoma (CS) and pulmonary blastoma (PB). These tumors are rare overall, making up approx. 0.1-0.4% of all lung malignancies. They are more commonly found in males who are heavy smokers, diagnosed at the age of 60 on average and follow an aggressive clinical course. The authors describe the case of a male patient with primary pleomorphic lung sarcoma and also include a review of the literature.</p>      <p><b>Key-words</b>: Lung neoplasms, pleomorphic sarcoma, conective and soft tissue neoplasms.</p>      ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p>Texto completo disponível apenas em PDF.</p>     <p>Full text only available in PDF format.</p>     <p>&nbsp;</p>      <p><b>Bibliografia</b></p>      <!-- ref --><p>1. Brambilla E, Travis WD, Colby TV, <i>et al</i>. The new World Health Organization classification of lung tumors. Eur Resp J 2001; 18:1059 -68.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000028&pid=S0873-2159200800040000600001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>2. Rossi G, Cavazza A, Sturm N, Migaldi M, Facciolongo N, Longo L, Maiorana A, Brambilla E. Pulmonary carcinoma with pleomorphic, sarcomatoid, or sarcomatous elements. A clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Path 2003; 27:311 -24.</p>      <p>3. Instituto Nacional de Câncer; Ministério da Saúde. A situação do câncer no Brasil. 1a ed. Rio de Janeiro (Brasil): INCA, 2006.</p>      <p>4. Chang YL, Lee YC, Shih JY, <i>et al. </i>Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non–small cell carcinoma. Lung Cancer 2001; 34:91 -97.</p>      <p>5. Travis WD, Travis JB, Devesa SS. Lung Cancer. Cancer 1995; 75: 191 -202.</p>      ]]></body>
<body><![CDATA[<p>6. Pereira JCN, Campos JRM. Outros tumores de pulmão in Andrade Filho LA. Cirurgia Torácica: Diagnóstico e Tratamento. Rio de Janeiro, Cultura Médica 2007: 105 -92.</p>      <p>7. Corpa-Rodruíguez ME, Mayoralas-Alises S, García-Sanchez J, Gil-Alonso JL, Díaz -Agero P, Casillas–Pajuello M. Postoperative course in 7 cases of primary sarcoma of the lung. Arch Bronchoneumol 2005; 41:634 -7.</p>      <p>8. Cordeiro PB. Tumores malignos menos frequentes in Saad Junior R, Carvalho WR, Ximenes Netto M, Forte V. Cirurgia Torácica Geral. São Paulo, Atheneu 2005: 481 -6</p>      <p>9. Kim YD, Lee CH, Lee MK, Jeong YJ, Kim JY, Park  DY, Sol MY. Primary alveolar soft part sarcoma of the lung. J Korean Med Sci 2007; 22:369 -72.</p>      <p>10. Terasaki H, Niki T, Hasegawa T, Yamada T, Suzuki K, Kusumoto M, Fujimoto K, Hayabuchi N, Matsuno Y, Shimoda T. Primary synovial sarcoma of the lung: a case report confirmed by molecular  detection of SYT-SSx fusion gene transcripts. Japan J Clin Oncol 2001; 31:212 -216.</p>      <p>11. Zamarrón C, Abdulkader I, Alvarez UC, Barón FJ, Prim JMG, Ledo RLA, Forteza J. Primary synovial sarcoma of the lung. Primary synovial sarcoma of the lung. Internal Medicine 2006; 6:79 -83.</p>      <p>12. Bezerra Junior ML, Costa ES, Nascimento MF, Mendes GLQ, Cavalcanti A, Pinel MIS.  Sarcoma sinovial bifásico de alto grau primário de pulmão. Rev Bras Cancerol 2003; 49:175 -78.</p>      <p>&nbsp;</p>      <p><sup><a href="#top1">1</a><a name="1"></a></sup> Especializando do S. Cirurgia    Torácica Oncológica – HC I – INCA/MS – Rio de Janeiro – Brasil</p>      <p><sup><a href="#top2">2</a></sup><a name="2"></a> Residente do S. de Cirurgia    Torácica Oncológica – HC I – INCA/MS – Rio de Janeiro – RJ</p>      ]]></body>
<body><![CDATA[<p><sup><a href="#top3">3</a><a name="3"></a></sup> Cirurgião de Tórax – S. Cirurgia    Torácica Oncológica – HC I – INCA/MS – Rio de Janeiro – Brasil</p>      <p><sup><a href="#top4">4</a><a name="4"></a></sup> Chefe do S. Cirurgia Torácica    Oncológica – HC I – Rio de Janeiro – RJ</p>      <p><sup><a href="#top5">5</a></sup><a name="5"></a> Patologista e Citopatologista    do S. de Anatomia Patológica do INCA/MS – Rio de Janeiro – Brasil</p>      <p><sup><a href="#top6">6</a><a name="6"></a></sup> Pneumologista do Grupo de    Oncologia Torácica do HC I – INCA/MS – Rio de Janeiro – Brasil</p>      <p>&nbsp;</p>      <p><b>Correspondência</b></p>      <p>Mauro Zamboni. Rua Sorocaba 464/302. CEP: 22271-110 - Rio de Janeiro - Brasil.    E-mail: <a href="mailto:mauro.zamboni@gmail.com">mauro.zamboni@gmail.com</a></p>      <p>&nbsp;</p>      <p>Recebido para publicação/received for publication: 08.03.03</p>     <p>Aceite para publicação/accepted for publication: 08.04.01 </p>      ]]></body>
<body><![CDATA[ ]]></body><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brambilla]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Travis]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
<name>
<surname><![CDATA[Colby]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The new World Health Organization classification of lung tumors.]]></article-title>
<source><![CDATA[Eur Resp J]]></source>
<year>2001</year>
<volume>18</volume>
<page-range>1059 -68</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
